000			02180 a2200625 4500
005			20250514170810.0
264		0	_c20041112
008			200411s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1704424 _2doi
040			_aNLM _beng _cNLM
100	1		_aPhillips, G L
245	0	0	_aActivity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. _h[electronic resource]
260			_bBone marrow transplantation _cApr 2004
300			_a781-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAmifostine _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHodgkin Disease _xtherapy
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xtherapy
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aRadiation-Protective Agents _xadministration & dosage
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Autologous
700	1		_aMeisenberg, B R
700	1		_aReece, D E
700	1		_aAdams, V R
700	1		_aBadros, A Z
700	1		_aBrunner, J L
700	1		_aFenton, R G
700	1		_aFilicko, J
700	1		_aGrosso, D L
700	1		_aHale, G A
700	1		_aHoward, D S
700	1		_aJohnson, V P
700	1		_aKniska, A
700	1		_aMarshall, K W
700	1		_aMookerjee, B
700	1		_aNath, R
700	1		_aRapoport, A P
700	1		_aSarkodee-Adoo, C
700	1		_aTakebe, N
700	1		_aVesole, D H
700	1		_aWagner, J L
700	1		_aFlomenberg, N
773	0		_tBone marrow transplantation _gvol. 33 _gno. 8 _gp. 781-7
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1704424 _zAvailable from publisher's website
999			_c14490987 _d14490987